Solvias to Perform Release Testing on World's First CRISPR-based Gene-Editing Therapy
/PRNewswire/ -- Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today that it will perform analytical release...
Stay updated with breaking news from Human Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today that it will perform analytical release...
Selin Sinem Erciyas, Zeynep Çağla Üstün, and Beste Turan of Gün and Partners explain a decision by the Turkish Civil Court for Intellectual and Industrial Property Rights that set an important precedent for the protection of pharmaceutical patent holders’ rights
The Pharmaceutical Journal from the Royal Pharmaceutical Society
HYQVIA [Immune Globulin Infusion 10% with Recombinant Human Hyaluronidase], the Only up to Once Monthly Subcutaneous Immunoglobulin Infusion to Treat CIDP, Can Be Administered by a Healthcare...
- Eisai Co., Ltd. announced today that the Scientific Advisory Group will convene to discuss the marketing authorization application of lecanemab , which is currently under review by the European...